Anzeige
Mehr »
Login
Samstag, 18.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Spezial Report: NASDAQ-FinTech mit 3.000% Wachstum und 500% Kurs-Chance!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
17 Leser
Artikel bewerten:
(0)

Vitamin Shoppe, Inc. Completes Secondary Offering

NORTH BERGEN, N.J., May 25 /PRNewswire-FirstCall/ -- Vitamin Shoppe, Inc. today announced the closing of the secondary public offering of its common stock, which was priced on May 29 at a public offering price of $23.50 per share. All of the shares of common stock were sold by certain stockholders of Vitamin Shoppe. In connection with the public offering, the underwriters exercised in full their option to purchase an additional 935,448 shares of common stock from the selling stockholders. As a result, a total of 7,171,768 shares were sold in the offering.

The selling stockholders received all of the proceeds from this offering, and Vitamin Shoppe did not receive any proceeds from the sale of shares in this offering. Irving Place Capital Partners II, L.P. is a principal stockholder of Vitamin Shoppe and was a selling stockholder in this offering. In addition, members of management of Vitamin Shoppe and certain of its other equity holders were also selling stockholders in the offering.

J.P. Morgan, BofA Merrill Lynch and Barclays Capital are acting as joint book-running managers for the offering. Stifel Nicolaus, Baird and Piper Jaffray are the co-managers of the offering.

The public offering is being made only by means of a prospectus, copies of which may be obtained from either:

J.P. Morgan Securities Inc. c/o Broadridge Financial Solutions 1155 Long Island Avenue Edgewood, NY 11717 BofA Merrill Lynch 4 World Financial Center New York, NY 10080 Attention: Preliminary Prospectus Department Email: Prospectus.Requests@ml.com Barclays Capital c/o Broadridge Financial Solutions 1155 Long Island Avenue Edgewood, NY 11717

A registration statement relating to shares of the common stock of Vitamin Shoppe has been declared effective by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.

About Vitamin Shoppe, Inc.

Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products based in North Bergen, New Jersey. The company sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids to customers located primarily in the United States.

Vitamin Shoppe, Inc.

CONTACT: Investors, Michael Archbold, Chief Financial Officer,
+1-201-624-3611, ir@vitaminshoppe.com; or Media, Susan McLaughlin, Director
Corporate Communications, +1-201-624-3134, smclaughlin@vitaminshoppe.com, or
Jill Yaffe of Allison & Partners, +1-646-428-0602,
vitaminshoppe@allisonpr.com

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2010 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.